News & Analysis as of

Tariffs Comment Period Medical Supplies

Foley Hoag LLP

USTR Seeking Public Comments on Proposed Tariff Increases on Chinese Goods

Foley Hoag LLP on

As reported in our previous client alert, on May 14, 2024, President Biden announced that he directed his Trade Representative to increase tariffs under Section 301 of the Trade Act of 1974 (Section 301) on a wide range of...more

McDermott Will & Emery

New Public-Comment Period Regarding Section 301 Tariffs Impacting Certain Medical-Care and COVID-19 Response Products

McDermott Will & Emery on

As the country continues to experience the effects of the COVID-19 pandemic, the Office of the US Trade Representative (USTR) has invited public comments on whether to continue excluding certain medical supplies from the...more

Sheppard Mullin Richter & Hampton LLP

USTR Grants New Section 301 Exclusions and Extends Existing Exclusions for Certain Chinese Medical Products

On December 29, 2020, the U.S. Trade Representative (USTR) posted a notice granting new Section 301 product exclusions and extending existing exclusions for COVID-19 medical care products. This action is in response to USTR’s...more

Holland & Knight LLP

Comments Sought on Section 301 Exclusions for China Imports Related to COVID-19

Holland & Knight LLP on

The Office of the U.S. Trade Representative (USTR) has issued a call for comments regarding the possible removal of Section 301 tariffs for medical-care products from China. The request for comments on the easing of Section...more

Hogan Lovells

USTR invites comments on potential Section 301 exclusions in response to the coronavirus

Hogan Lovells on

The Office of the U.S. Trade Representative (USTR) has announced it is accepting comments on potential Section 301 tariff exclusions for Chinese imports necessary to respond to the coronavirus. USTR is likely to expeditiously...more

ArentFox Schiff

COVID-19 Impact on Section 301 China Tariffs: USTR Excludes Some Healthcare Products, Solicits Requests to Exclude More

ArentFox Schiff on

On Wednesday, March 25, 2020, the U.S. Trade Representative (USTR) published a Federal Register notice requesting comments on the removal of Section 301 tariffs from Chinese medical-care products—including those that have...more

Akin Gump Strauss Hauer & Feld LLP

USTR Requests Comments on Section 301 Tariffs on COVID-19 Related Products

- Late on Friday, March 20, 2020, USTR announced that it has opened a new public comment period for businesses and government agencies to request additional product exclusions from Section 301 duties for certain...more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide